RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Physis Capital
P

Physis Capital portfolio

Physis Capital has 4 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 4.
Deals, last 12 months: 2.
Capital in their rounds: $63.56M.
Latest deal: Theater · Sep 10, 2026.
About this page

Its most recent investment on record is Theater's $7.8M Series A round in September 2026, alongside Niveshaay and Prath Ventures. By category, its portfolio leans toward Consumer and social (2) and Health and bio (2). It has co-invested with Prath Ventures, Niveshaay and Multiply Ventures.

What Physis Capital invests in

Physis Capital recent investments

CompanyRoundDateAlongside
TTheaterSeries A · $7.8MNiveshaay (lead), Prath Ventures
LLissunSeries A · $5.76MNew Age India Fund, IvyCap Ventures, SucSEED Ventures +5
RRecur ClubSeries A · $50MFinvolve, String Ventures, Info Edge Ventures (lead) +1

How Physis Capital invests

StageDealsCapital in rounds
Series A 3 100%$63.56M
YearDealsCapital in rounds
2025 1 33%$50M
2026 2 67%$13.56M

Physis Capital portfolio companies

CompanyRound with Physis CapitalTotal raisedLatest raise
TTheater
Commerce and retail
Series A · $7.8M$7.8MSep 10, 2026
Series A
LLissun
Health and bio
Series A · $5.76M$8.06MAug 18, 2026
Series A
RRecur Club
Fintech
Series A · $50M$80MOct 4, 2025
Series A
NNat Habit
Health and bio
backer$28.88MOct 10, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Consumer and social).

How this is counted

Share is of the 3 rounds on Recent Funding that name Physis Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Physis Capital, which is a subset of its real portfolio. API: /api/v1/investors/physis-capital (get a free API key). More: the most active VC firms and new venture capital funds.